These high intratumoral CD8 T-cell frequencies required the presence of antigen peptide, clearly indicating that priming, clonal expansion and tumor infiltration of T cells prior to antibody treatment were essential biological principles of this therapy. The gene discussed is CD8A; the disease is neoplasm.